This inventor holds 1 USPTO granted patent. Top assignee: Helm Ag. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Katja Stritzke: Innovator in Pharmaceutical Chemistry
Introduction
Katja Stritzke is a prominent inventor based in Hamburg, Germany. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative drug formulations. Her work has garnered attention for its potential impact on the treatment of various medical conditions.
Latest Patents
Katja Stritzke holds a patent for "Amorphous aripiprazole and process for the preparation thereof." This invention focuses on morphologically stabilized amorphous aripiprazole and the process for preparing the same. This patent represents her commitment to advancing pharmaceutical science and improving drug efficacy.
Career Highlights
Throughout her career, Katja has demonstrated a strong dedication to research and innovation. She is currently associated with Helm AG, where she collaborates with other talented professionals in the field. Her work has not only contributed to her personal achievements but has also advanced the goals of her organization.
Collaborations
Katja has worked alongside esteemed colleagues such as Uwe Löffler and Klaus Glänzer. These collaborations have fostered a dynamic environment for innovation and have led to the successful development of new pharmaceutical solutions.
Conclusion
Katja Stritzke's contributions to pharmaceutical chemistry exemplify the spirit of innovation in the industry. Her patent and collaborative efforts highlight her role as a key player in advancing medical science.